Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature
2012
Purpose
A 128-gene signature has been proposed to predict outcome in patients with stages II and III colorectal cancers. In the present study, we aimed to reproduce and validate the 128-gene signature in external and independent material.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
31
References
21
Citations
NaN
KQI